BioLineRx (BLRX) Operating Income (2011 - 2026)
BioLineRx (BLRX) reported Operating Income of -$3.57 million for the quarter ended Jun 30, 2026, compared with -$2.3 million a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Operating Income (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, BioLineRx's Operating Income came in at -$12.17 million; for the year ended Dec 31, 2025, it came in at -$10.29 million.
- By year, Operating Income came in at -$20.41 million in the year ended Dec 31, 2024, -$49.69 million in the year ended Dec 31, 2023, -$29.16 million in the year ended Dec 31, 2022 and -$24.78 million in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Operating Income since the quarter ended Dec 31, 2024.
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$3 million (quarter ended Mar 31, 2026), -$3.39 million (quarter ended Dec 31, 2025) and -$2.21 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | BioLineRx | 6.34 Bn | 6.35 Bn | 235,000.00 | -3.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.57 Mn |
| Mar 31, 2026 | -3.00 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | -2.21 Mn |
| Jun 30, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.39 Mn |
| Dec 31, 2024 | -4.43 Mn |
| Sep 30, 2024 | -5.39 Mn |
| Jun 30, 2024 | -5.77 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | -9.92 Mn |
| Mar 31, 2023 | -8.86 Mn |
| Dec 31, 2022 | -8.40 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -7.60 Mn |
| Mar 31, 2022 | -6.08 Mn |
| Dec 31, 2021 | -6.60 Mn |
| Sep 30, 2021 | -6.22 Mn |
API Access
BioLineRx Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();